KalVista Pharmaceuticals, Inc. (KALV) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1156480,
    "name": "KalVista Pharmaceuticals, Inc.",
    "stock_name": "KalVista Pharmaceuticals, Inc.",
    "full_name": "KalVista Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/kalvista-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "16.40",
    "chg": 2.88,
    "chgp": "21.3%",
    "dir": 1,
    "prev_price": "13.52",
    "mcapval": "797.26",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US4834971032",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.53 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kalvista-pharmaceuticals-inc-1156480-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "KalVista Pharmaceuticals Experiences Revision in Stock Evaluation Amid Market Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kalvista-pharmaceuticals-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-price-decline-3619834",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/KalVistaPharmac_technicaldot_3619834.png",
        "date": "2025-10-14 15:56:14",
        "description": "KalVista Pharmaceuticals, Inc. has experienced notable stock price fluctuations, currently at $11.32. The company has a 52-week high of $17.28 and a low of $7.30. While year-to-date returns are strong compared to the S&P 500, recent performance has shown a decline over the past month."
      },
      {
        "title": "Is KalVista Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kalvista-pharmaceuticals-inc-technically-bullish-or-bearish-3617707",
        "imagepath": "",
        "date": "2025-10-14 11:38:59",
        "description": "As of 10 October 2025, the technical trend for KalVista Pharmaceuticals, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed signals across different indicators. The MACD shows a mildly bearish signal on the weekly timeframe, while it remains bullish on the monthly timeframe. The Bollinger Bands indicate bearish conditions on both weekly and monthly charts. Moving averages are mildly bullish on the daily timeframe, but the KST and Dow Theory show mildly bearish signals on the weekly and monthly timeframes. Overall, the indicators suggest a lack of strong momentum in either direction. Multi-period return data is not available for comparison with the S&P 500...."
      },
      {
        "title": "Is KalVista Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kalvista-pharmaceuticals-inc-technically-bullish-or-bearish-3614701",
        "imagepath": "",
        "date": "2025-10-13 11:40:43",
        "description": "As of 10 October 2025, the technical trend for KalVista Pharmaceuticals, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD and KST are both mildly bearish, while the monthly MACD and KST are bullish. The Bollinger Bands indicate a bearish trend for both weekly and monthly periods. Daily moving averages show a mildly bullish signal. \n\nIn terms of performance, KalVista has underperformed the S&P 500 over the past month with a return of -25.28% compared to the S&P 500's 0.31%, but it has significantly outperformed over the 3-year period with a return of 145.20% versus the S&P 500's 81.39%...."
      },
      {
        "title": "Is KalVista Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kalvista-pharmaceuticals-inc-technically-bullish-or-bearish-3613034",
        "imagepath": "",
        "date": "2025-10-12 11:28:13",
        "description": "As of 10 October 2025, the technical trend for KalVista Pharmaceuticals, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed indicators influencing this view. The weekly MACD is mildly bearish, while the monthly MACD remains bullish. The Bollinger Bands indicate a bearish trend on both weekly and monthly time frames. Daily moving averages show a mildly bullish signal, but the KST, Dow Theory, and OBV are all mildly bearish on the weekly basis. \n\nIn terms of multi-period returns, the stock has underperformed the S&P 500 over the past month and year, with a return of -25.28% compared to the S&P's 0.31% over the last month, and 4.64% compared to the S&P's 13.36% over the last year. However, it has significantly outperformed the S&P 500 on a 3-year basis with a return of 145.20% versus 81.39%...."
      },
      {
        "title": "Is KalVista Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kalvista-pharmaceuticals-inc-technically-bullish-or-bearish-3547621",
        "imagepath": "",
        "date": "2025-09-20 19:59:27",
        "description": "As of 12 September 2025, the technical trend for KalVista Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD remains bullish, while the monthly MACD is also bullish, indicating positive momentum. The daily moving averages are mildly bullish, supporting the overall stance. However, the KST and OBV indicators show mild bearishness on a weekly basis, which tempers the bullish outlook. The Dow Theory suggests a mildly bullish trend on a monthly basis, but no trend on a weekly basis. \n\nIn terms of returns, the stock has outperformed the S&P 500 year-to-date with a return of 63.87% compared to 12.22%, and over the past year with 29.84% versus 17.14%. However, it has underperformed over the longer three and five-year periods. Overall, the current technical stance is mildly bullish, but with some caution due to mixed indicators...."
      },
      {
        "title": "Is KalVista Pharmaceuticals, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kalvista-pharmaceuticals-inc-overvalued-or-undervalued-3543940",
        "imagepath": "",
        "date": "2025-09-20 18:33:12",
        "description": "As of 11 September 2025, the valuation grade for KalVista Pharmaceuticals, Inc. has moved from does not qualify to risky, indicating a heightened level of concern regarding its financial health. The company appears to be overvalued given its significant negative metrics, including a Price to Book Value of 4.92 and an ROE of -121.18%. Additionally, the EV to EBIT and EV to EBITDA ratios are both negative, at -3.10 and -3.12 respectively, which further underscores the company's financial struggles.\n\nIn comparison to its peers, KalVista's valuation ratios are concerning; for instance, Icosavax, Inc. has a P/E of -7.9922, while Nurix Therapeutics, Inc. shows a P/E of -3.5769, both indicating similar risk profiles. In contrast, SIGA Technologies, Inc. stands out with a more attractive P/E of 7.5458. Notably, while KalVista has shown a YTD return of 63.87%, it has underperformed against the S&P 500's return of 12..."
      },
      {
        "title": "KalVista Pharmaceuticals Experiences Evaluation Revision Amidst Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kalvista-pharmaceuticals-technical-trend-shifts-from-bullish-to-mildly-bullish-amid-price-decline-3522808",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/KalVistaPharmac_technicaldot_3522808.png",
        "date": "2025-09-16 18:47:36",
        "description": "KalVista Pharmaceuticals, Inc. has recently revised its evaluation amid changing market conditions. The stock is priced at $13.62, with a notable year-to-date return of 60.80%. Despite a strong annual performance of 22.26%, the company has faced challenges over the past three years, reflecting fluctuating market dynamics."
      }
    ],
    "total": 12,
    "sid": "1156480",
    "stock_news_url": "https://www.marketsmojo.com/news/kalvista-pharmaceuticals-inc-1156480"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

KalVista Pharmaceuticals Experiences Revision in Stock Evaluation Amid Market Fluctuations

2025-10-14 15:56:14

KalVista Pharmaceuticals, Inc. has experienced notable stock price fluctuations, currently at $11.32. The company has a 52-week high of $17.28 and a low of $7.30. While year-to-date returns are strong compared to the S&P 500, recent performance has shown a decline over the past month.

Is KalVista Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-14 11:38:59

As of 10 October 2025, the technical trend for KalVista Pharmaceuticals, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed signals across different indicators. The MACD shows a mildly bearish signal on the weekly timeframe, while it remains bullish on the monthly timeframe. The Bollinger Bands indicate bearish conditions on both weekly and monthly charts. Moving averages are mildly bullish on the daily timeframe, but the KST and Dow Theory show mildly bearish signals on the weekly and monthly timeframes. Overall, the indicators suggest a lack of strong momentum in either direction. Multi-period return data is not available for comparison with the S&P 500....

Is KalVista Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-13 11:40:43

As of 10 October 2025, the technical trend for KalVista Pharmaceuticals, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD and KST are both mildly bearish, while the monthly MACD and KST are bullish. The Bollinger Bands indicate a bearish trend for both weekly and monthly periods. Daily moving averages show a mildly bullish signal. In terms of performance, KalVista has underperformed the S&P 500 over the past month with a return of -25.28% compared to the S&P 500's 0.31%, but it has significantly outperformed over the 3-year period with a return of 145.20% versus the S&P 500's 81.39%....

Is KalVista Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-12 11:28:13

As of 10 October 2025, the technical trend for KalVista Pharmaceuticals, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed indicators influencing this view. The weekly MACD is mildly bearish, while the monthly MACD remains bullish. The Bollinger Bands indicate a bearish trend on both weekly and monthly time frames. Daily moving averages show a mildly bullish signal, but the KST, Dow Theory, and OBV are all mildly bearish on the weekly basis. In terms of multi-period returns, the stock has underperformed the S&P 500 over the past month and year, with a return of -25.28% compared to the S&P's 0.31% over the last month, and 4.64% compared to the S&P's 13.36% over the last year. However, it has significantly outperformed the S&P 500 on a 3-year basis with a return of 145.20% versus 81.39%....

Is KalVista Pharmaceuticals, Inc. technically bullish or bearish?

2025-09-20 19:59:27

As of 12 September 2025, the technical trend for KalVista Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD remains bullish, while the monthly MACD is also bullish, indicating positive momentum. The daily moving averages are mildly bullish, supporting the overall stance. However, the KST and OBV indicators show mild bearishness on a weekly basis, which tempers the bullish outlook. The Dow Theory suggests a mildly bullish trend on a monthly basis, but no trend on a weekly basis. In terms of returns, the stock has outperformed the S&P 500 year-to-date with a return of 63.87% compared to 12.22%, and over the past year with 29.84% versus 17.14%. However, it has underperformed over the longer three and five-year periods. Overall, the current technical stance is mildly bullish, but with some caution due to mixed indicators....

Is KalVista Pharmaceuticals, Inc. overvalued or undervalued?

2025-09-20 18:33:12

As of 11 September 2025, the valuation grade for KalVista Pharmaceuticals, Inc. has moved from does not qualify to risky, indicating a heightened level of concern regarding its financial health. The company appears to be overvalued given its significant negative metrics, including a Price to Book Value of 4.92 and an ROE of -121.18%. Additionally, the EV to EBIT and EV to EBITDA ratios are both negative, at -3.10 and -3.12 respectively, which further underscores the company's financial struggles. In comparison to its peers, KalVista's valuation ratios are concerning; for instance, Icosavax, Inc. has a P/E of -7.9922, while Nurix Therapeutics, Inc. shows a P/E of -3.5769, both indicating similar risk profiles. In contrast, SIGA Technologies, Inc. stands out with a more attractive P/E of 7.5458. Notably, while KalVista has shown a YTD return of 63.87%, it has underperformed against the S&P 500's return of 12...

KalVista Pharmaceuticals Experiences Evaluation Revision Amidst Mixed Market Signals

2025-09-16 18:47:36

KalVista Pharmaceuticals, Inc. has recently revised its evaluation amid changing market conditions. The stock is priced at $13.62, with a notable year-to-date return of 60.80%. Despite a strong annual performance of 22.26%, the company has faced challenges over the past three years, reflecting fluctuating market dynamics.

View All News